These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10859685)

  • 1. Alzheimer's disease revisited.
    Newman PE
    Med Hypotheses; 2000 May; 54(5):774-6. PubMed ID: 10859685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aluminum levels in brain in Alzheimer's disease.
    Trapp GA; Miner GD; Zimmerman RL; Mastri AR; Heston LL
    Biol Psychiatry; 1978 Dec; 13(6):709-18. PubMed ID: 737258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of S-adenosylmethionine, S-adenosylhomocysteine, and polyunsaturated fatty acids in predementia syndromes and Alzheimer's disease.
    Panza F; Frisardi V; Capurso C; D'Introno A; Colacicco AM; Vendemiale G; Capurso A; Solfrizzi V
    J Alzheimers Dis; 2009; 16(3):467-70. PubMed ID: 19276539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity and potential mechanism of sulfatide deficiency in Alzheimer's disease: an electrospray ionization mass spectrometric study.
    Cheng H; Xu J; McKeel DW; Han X
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):809-18. PubMed ID: 14528918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in predementia syndromes and Alzheimer's disease.
    Panza F; Capurso C; D'Introno A; Colacicco AM; Capurso A; Solfrizzi V
    Neurobiol Aging; 2008 Mar; 29(3):478-80. PubMed ID: 17125887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease.
    Selley ML
    Neurobiol Aging; 2007 Dec; 28(12):1834-9. PubMed ID: 16996649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aluminum: a possible neurotoxic agent in Alzheimer's disease.
    Crapper DR; Krishnan SS; De Boni U; Tomko GJ
    Trans Am Neurol Assoc; 1975; 100():154-6. PubMed ID: 1241624
    [No Abstract]   [Full Text] [Related]  

  • 10. Aluminum induced oxidative events and its relation to inflammation: a role for the metal in Alzheimer's disease.
    Campbell A; Bondy SC
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):721-30. PubMed ID: 10875435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.
    Ringman JM; O'Neill J; Geschwind D; Medina L; Apostolova LG; Rodriguez Y; Schaffer B; Varpetian A; Tseng B; Ortiz F; Fitten J; Cummings JL; Bartzokis G
    Brain; 2007 Jul; 130(Pt 7):1767-76. PubMed ID: 17522104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mercury and Alzheimer's disease].
    Mutter J; Naumann J; Schneider R; Walach H
    Fortschr Neurol Psychiatr; 2007 Sep; 75(9):528-38. PubMed ID: 17628833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new inducible transferrin-independent iron uptake system involved with aluminum accumulation in the brain of patients with Alzheimer's disease].
    Oshiro S
    Tanpakushitsu Kakusan Koso; 1995 Aug; 40(11):1738-43. PubMed ID: 7676035
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatty acids, lipid metabolism and Alzheimer pathology.
    Hooijmans CR; Kiliaan AJ
    Eur J Pharmacol; 2008 May; 585(1):176-96. PubMed ID: 18378224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
    Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
    Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
    Allan LM; Ballard CG; Burn DJ; Kenny RA
    J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.